Repare Therapeutics (RPTX) Short Interest Ratio & Short Volume → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free RPTX Stock Alerts $3.53 -0.04 (-1.12%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Repare Therapeutics Short Interest DataCurrent Short Volume682,500 sharesPrevious Short Volume608,300 sharesChange Vs. Previous Month+12.20%Dollar Volume Sold Short$2.12 millionShort Interest Ratio / Days to Cover3.5Last Record DateApril 30, 2024Outstanding Shares42,440,000 sharesFloat Size28,690,000 sharesShort Percent of Float2.38%Today's Trading Volume114,354 sharesAverage Trading Volume200,547 sharesToday's Volume Vs. Average57% Short Selling Repare Therapeutics ? Sign up to receive the latest short interest report for Repare Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRPTX Short Interest Over TimeRPTX Days to Cover Over TimeRPTX Percentage of Float Shorted Over Time Ad Behind the MarketsInvest in the "Trojan Horse" of Alzheimer's TreatmentThis one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics.Click here and learn how you can invest in this incredible opportunity>>> Repare Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024682,500 shares $2.12 million +12.2%2.4%3.5 $3.10 4/15/2024608,300 shares $2.11 million -10.7%2.1%4.7 $3.47 3/31/2024681,000 shares $3.21 million +3.4%2.4%4.6 $4.71 3/15/2024658,600 shares $3.48 million -11.4%2.3%4.2 $5.29 2/29/2024743,300 shares $5.17 million -8.5%2.6%3.7 $6.95 2/15/2024812,500 shares $5.65 million -52.8%2.8%3.6 $6.95 Get the Latest News and Ratings for RPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,720,000 shares $11.25 million -20.0%5.4%5.7 $6.54 1/15/20242,150,000 shares $14.06 million -2.7%6.8%6 $6.54 12/31/20232,210,000 shares $16.13 million -12.3%7.0%5.9 $7.30 12/15/20232,520,000 shares $17.01 million -7.4%7.9%6.9 $6.75 11/30/20232,720,000 shares $14.01 million +25.9%8.6%7.8 $5.15 11/15/20232,160,000 shares $11.43 million +24.1%6.8%6.9 $5.29 10/31/20231,740,000 shares $5.92 million +10.8%5.5%7.4 $3.40 10/15/20231,570,000 shares $8.29 million +23.6%4.9%9.9 $5.28 9/30/20231,270,000 shares $15.34 million +1.6%4.0%10.8 $12.08 9/15/20231,250,000 shares $12.90 million +4.2%3.9%12.3 $10.32 8/31/20231,200,000 shares $11.71 million -3.2%3.8%12.5 $9.76 8/15/20231,240,000 shares $12.05 million +0.8%3.9%12.1 $9.72 7/31/20231,230,000 shares $11.32 million -5.4%3.9%12.6 $9.20 7/15/20231,300,000 shares $14.14 million +2.4%4.1%13.7 $10.88 6/30/20231,270,000 shares $13.44 million -5.9%4.0%12.4 $10.58 6/15/20231,350,000 shares $16.67 million +7.1%4.3%13 $12.35 5/31/20231,260,000 shares $13.37 million -2.3%4.0%12.2 $10.61 5/15/20231,290,000 shares $13.08 million -4.4%4.1%12.8 $10.14 4/30/20231,350,000 shares $12.10 million -12.9%4.3%12 $8.96 4/15/20231,550,000 shares $14.06 million -8.3%5.0%12.6 $9.07 3/31/20231,690,000 shares $16.63 million +1.2%5.4%13.4 $9.84 3/15/20231,670,000 shares $16.60 million +6.4%5.4%11.6 $9.94 2/28/20231,570,000 shares $16.09 million +4.0%5.1%9.7 $10.25 2/15/20231,510,000 shares $17.41 million +4.9%4.9%9.2 $11.53 1/31/20231,440,000 shares $17.80 million -7.1%4.7%7.7 $12.36 1/15/20231,550,000 shares $19.92 million +22.1%5.0%8.8 $12.85 12/30/20221,270,000 shares $18.68 million +64.2%4.1%7.5 $14.71 12/15/2022773,300 shares $11.55 million -39.6%2.5%4.9 $14.93 11/30/20221,280,000 shares $20.52 million -18.0%4.2%8.9 $16.03 11/15/20221,560,000 shares $26.69 million +0.7%5.1%11.7 $17.11 10/31/20221,550,000 shares $23.34 million -1.9%5.1%12.6 $15.06 10/15/20221,580,000 shares $21.09 million -1.9%5.2%10.8 $13.35 9/30/20221,610,000 shares $19.53 million +4.6%5.3%10.5 $12.13 9/15/20221,540,000 shares $20.14 million -4.4%5.0%9.1 $13.08“Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. RPTX Short Interest - Frequently Asked Questions What is Repare Therapeutics' current short interest? Short interest is the volume of Repare Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 682,500 shares of RPTX short. 2.38% of Repare Therapeutics' shares are currently sold short. Learn More on Repare Therapeutics' current short interest. What is a good short interest ratio for Repare Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPTX shares currently have a short interest ratio of 4.0. Learn More on Repare Therapeutics's short interest ratio. What is a good short interest percentage for Repare Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.38% of Repare Therapeutics' floating shares are currently sold short. Is Repare Therapeutics' short interest increasing or decreasing? Repare Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 682,500 shares, an increase of 12.2% from the previous total of 608,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Repare Therapeutics' float size? Repare Therapeutics currently has issued a total of 42,440,000 shares. Some of Repare Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repare Therapeutics currently has a public float of 28,690,000 shares. How does Repare Therapeutics' short interest compare to its competitors? 2.38% of Repare Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Repare Therapeutics: CervoMed Inc. (1.06%), ProQR Therapeutics (0.41%), CytomX Therapeutics, Inc. (4.62%), scPharmaceuticals Inc. (17.76%), Prelude Therapeutics Incorporated (2.43%), Skye Bioscience, Inc. (0.29%), I-Mab (1.43%), Renovaro Inc. (2.09%), Capricor Therapeutics Inc (13.14%), InterCure Ltd. (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Repare Therapeutics stock? Short selling RPTX is an investing strategy that aims to generate trading profit from Repare Therapeutics as its price is falling. RPTX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Repare Therapeutics? A short squeeze for Repare Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RPTX, which in turn drives the price of the stock up even further. How often is Repare Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CRVO Short Interest Data PRQR Short Interest Data CTMX Short Interest Data SCPH Short Interest Data PRLD Short Interest Data SKYE Short Interest Data IMAB Short Interest Data RENB Short Interest Data CAPR Short Interest Data INCR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPTX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe 1,000X Crypto PlaybookTrue Market InsidersWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media